Ola Rizq

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Journal: Blood
Published: October 16, 2025

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Journal: Blood
Published: October 16, 2025

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

Journal: Nature communications
Published: April 02, 2025

Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span.

Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span.

Journal: Blood
Published: June 17, 2024

Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Journal: Leukemia
Published: July 18, 2023

The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.

The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.

Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2022

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Journal: Leukemia
Published: May 25, 2022

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

Journal: Scientific reports
Published: June 25, 2021

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells.

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells.

Journal: Scientific reports
Published: June 29, 2020

PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.

PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.

Journal: Leukemia
Published: May 05, 2020

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma.

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma.

Journal: Cancer science
Published: August 28, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026